4.65
price down icon4.02%   -0.195
after-market After Hours: 4.84 0.19 +4.09%
loading

Endra Life Sciences Inc Stock (NDRA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
90.74%
2.7805
1.4578 3.1291 2.9946 2.9393
Depreciation and Amortization
30.10%
0.0153
0.0219 - - -
Operating Income/Loss
90.74%
-2.7805
-1.4578 -3.1291 -2.9946 -2.9393
Income/Loss From Continuing Operations Before Tax
90.18%
-2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
90.18%
-2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Net Income/Loss
290.18%
2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
5.5514
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$156.00
price down icon 1.50%
diagnostics_research DGX
$175.41
price up icon 0.78%
diagnostics_research LH
$252.87
price up icon 0.57%
diagnostics_research WAT
$380.83
price up icon 0.41%
diagnostics_research MTD
$1,308.89
price down icon 0.08%
diagnostics_research IQV
$190.97
price down icon 1.94%
Cap:     |  Volume (24h):